Tuesday, March 31, 2009
FDA says Bristol-Myers diabetes drug appears to meet standards for heart safety
WASHINGTON - Federal health officials in the United States said Monday a potential blockbuster diabetes medication from Bristol-Myers Squibb appears free from heart-related side effects that have plagued similar treatments....More
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment